Explanation
Prostate-specifcantigen (PSA)
Aman ofadvanced agepresenting with bony metastasesismostuikelytohavemetastatic prostatecancer.
withthepossible exception ofprostate-specificantigen (PSA).tumourmarkersdonot have sufficient
sensitivityorspecificityforuseinscreenina.pSAcanbeusedtoscreenfor prostatecancer.athouah
population screeninaiscontroversiau.tcanasobeusedtodetect recurrenceofthemalianancv.andisusefut
intheinvestiaationofadenocarcinomaofunknown primarv
@1MINENDOCRINE
